文献速递血栓与止血

FVIIa通过EPCR-PAR1信号诱导内皮细胞释放促凝胞外囊泡

Factor VIIa induces extracellular vesicles from the endothelium: a potential mechanism for its hemostatic effect.
PubMed 文献 · Blood · 2021-01-01

本研究探讨FVIIa-EPCR-PAR1信号在止血中的作用。体外和体内实验显示FVIIa通过EPCR和PAR1诱导内皮细胞释放胞外囊泡,这些囊泡具有促凝活性,输注或内源性生成可增强止血效果并减少失血。

要点

  • FVIIa通过EPCR-PAR1信号诱导内皮细胞释放胞外囊泡。
  • FVIIa生成的胞外囊泡具有增强的促凝活性。
  • 输注FVIIa生成的囊泡可增加损伤部位凝血酶生成并减少失血。

核心结论

  • FVIIa通过FVIIa-EPCR-PAR1信号诱导内皮细胞释放胞外囊泡,这些囊泡参与FVIIa的止血效应。

研究设计与样本

  • 体外内皮细胞实验与体内小鼠模型研究,使用野生型、EPCR过表达、PAR1-R46Q突变、EPCR缺陷及PAR1-R41Q突变小鼠。

主要发现

  • FVIIa在体外和体内均诱导内皮细胞释放胞外囊泡,沉默EPCR或PAR1可阻断此效应。
  • FVIIa处理的野生型、EPCR过表达和PAR1-R46Q突变小鼠循环胞外囊泡数量增加,而EPCR缺陷或PAR1-R41Q突变小鼠无增加。
  • FVIIa诱导的胞外囊泡具有增强的促凝活性。
  • 输注FVIIa生成的胞外囊泡(而非对照囊泡)至血小板清除小鼠,增加损伤部位凝血酶生成并减少失血。
  • 给予FVIIa生成的胞外囊泡或通过给予FVIIa内源性生成囊泡,均增强FVIIa的止血效果。

临床怎么用

  • FVIIa的止血作用部分通过诱导内皮释放促凝胞外囊泡实现,提示胞外囊泡可能作为止血治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recombinant factor FVIIa (rFVIIa) is used as a hemostatic agent to treat bleeding disorders in hemophilia patients with inhibitors and other groups of patients. Our recent studies showed that FVIIa binds endothelial cell protein C receptor (EPCR) and induces protease-activated receptor 1 (PAR1)-mediated biased signaling. The importance of FVIIa-EPCR-PAR1-mediated signaling in hemostasis is unknown. In the present study, we show that FVIIa induces the release of extracellular vesicles (EVs) from endothelial cells both in vitro and in vivo. Silencing of EPCR or PAR1 in endothelial cells blocked the FVIIa-induced generation of EVs. Consistent with these data, FVIIa treatment enhanced the release of EVs from murine brain endothelial cells isolated from wild-type (WT), EPCR-overexpressing, and PAR1-R46Q-mutant mice, but not EPCR-deficient or PAR1-R41Q-mutant mice. In vivo studies revealed that administration of FVIIa to WT, EPCR-overexpressing, and PAR1-R46Q-mutant mice, but not EPCR-deficient or PAR1-R41Q-mutant mice, increased the number of circulating EVs. EVs released in response to FVIIa treatment exhibit enhanced procoagulant activity. Infusion of FVIIa-generated EVs and not control EVs to platelet-depleted mice increased thrombin generation at the site of injury and reduced blood loss. Administration of FVIIa-generated EVs or generation of EVs endogenously by administering FVIIa augmented the hemostatic effect of FVIIa. Overall, our data reveal that FVIIa treatment, through FVIIa-EPCR-PAR1 signaling, releases EVs from the endothelium into the circulation, and these EVs contribute to the hemostatic effect of FVIIa.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Das K, Keshava S, Ansari SA, et al. Factor VIIa induces extracellular vesicles from the endothelium: a potential mechanism for its hemostatic effect. Blood. 2021. PMID: 33534910. doi:10.1182/blood.2020008417

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。